1199 Efficacy of bevacizumab versus PARP inhibitors as maintenance therapy after first-line platinum-based chemotherapy for homologous recombination proficient, advanced high-grade ovarian cancer patients: a retrospective study
Poster and E-Posters（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要